The Indian Journal of Pediatrics

, Volume 85, Issue 6, pp 411–412 | Cite as

Biomarkers for Diagnosing Ventilator Associated Pneumonia: Is that the Way Forward?

Editorial Commentary


Compliance with Ethical Standards

Conflict of Interest



  1. 1.
    CDC: Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU] Event). pg1–16. Available at: Accessed 26 Feb 2018.
  2. 2.
    Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867–903.CrossRefPubMedGoogle Scholar
  3. 3.
    Luyt CE, Combes A, Reynaud C, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med. 2008;34:1434–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem. 2008;45:293–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax. 2010;65:201–7.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350:451–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Anand NJ, Zuick S, Klesney-Tait J, Kollef MH. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest. 2009;135:641–7.Google Scholar
  8. 8.
    Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care. 2008;12:R11.Google Scholar
  9. 9.
    Srinivasan R, Song Y, Wiener-Kronish J, Flori HR. Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Pediatr Crit Care Med. 2011;12:21–7.Google Scholar
  10. 10.
    Determann RM, Millo JL, Waddy S, Lutter R, Garrard CS, Schultz MJ. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study. BMC Pulm Med. 2009;9:49.Google Scholar
  11. 11.
    Flanagan PG, Jackson SK, Findlay G. Diagnosis of gram negative, ventilator associated pneumonia by assaying endotoxin in bronchial lavage fluid. J Clin Pathol. 2001;54:107–10.Google Scholar
  12. 12.
    Tekerek NU, Akyildiz BN, Ercal BD, Muhtaroglu S. New biomarkers to diagnose ventilator associated pneumonia: pentraxin 3 and surfactant protein D. Indian J Pediatr. 2018.
  13. 13.
    Afify MH, Shaheen EA, El-Dahdouh SS, El-Feky HM. Comparison between bronchoscopic BAL and non-bronchoscopic BAL in patients with VAP. Egyptian J Chest Dis Tubercul. 2016;65:113–9.CrossRefGoogle Scholar
  14. 14.
    Said AS, Abd-Elaziz MM, Farid MM, et al. Evolution of surfactant protein-D levels in children with ventilator-associated pneumonia. Pediatr Pulmonol. 2012;47:292–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Srinivasan R, Song Y, Wiener-Kronish J, Flori H. A pilot study of biological markers of host defense in pediatric ventilator−associated pneumonia [VAP]. Am J Respir Crit Care Med. 2009;179:A2588.Google Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  1. 1.Department of PediatricsAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations